Cough Variant Asthma
Conditions
Interventions
Control Group:Budesonide and Formoterol Fumarate Powder for Inhalation(160ug:4.5ug*60take),one puff each time, twice a day, without Chinese medicine.
Intervention Group:Budesonide and Formoterol Fumarate Powder for Inhalation(160ug:4.5ug*60take),one puff each time, twice a day + Shufengzhike fomula,one packet each time, twice a day.
Sponsors
Guangzhou Panyu Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Meet the western medical diagnostic criteria for CVA and the Chinese medicine diagnosis is wind-cold against the lungs; (2) Patients aged 18-80 years (inclusive); (3) Voluntarily participate and sign an informed consent form after fully understanding the treatment plan of this experiment; (4) If they have other diseases at the same time, but the consultation period does not affect this study and does not require special treatment; Patients who fulfill all the above conditions will be included as cases.
Exclusion criteria
Exclusion criteria: (1) Those with confirmed diagnosis of other chronic respiratory diseases, such as chronic bronchitis and interstitial pulmonary fibrosis; (2) Patients with missing medical record information; (3) Patients with a previous history of chronic heart failure, hepatic and renal insufficiency, and other combinations of more serious primary diseases of other systems; (4) Pregnant and lactating patients; (5) Patients who are intolerant or allergic to the study drug; (6) Subjects with poor compliance, using therapies other than the study or changing therapies on their own during the treatment period; Subjects meeting any of the above were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale;Cough Evaluation Test;Cough relief time and Cough disappearance time;Clinical Syndrome Score of Chinese medicine;Leicester Cough Questionnaire; | — |
Countries
China
Contacts
Public ContactSheng Luo
Guangzhou Panyu Hospital of Chinese Medicine
Outcome results
None listed